Masashi Shingai
5PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 15, 2025
ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4+ and CD8+ T-cell responses and neutralizing antibody induction.Tomomi Kawakita, Toshiki Sekiya, Yayoi Kameda
|Feb 07, 2024
Extraction of the CDRH3 sequence of the mouse antibody repertoire selected upon influenza virus infection by subtraction of the background antibody repertoire.Masashi Shingai, Sayaka Iida, Naoko Kawai
|Jun 10, 2023
Two Modes of Th1 Polarization Induced by Dendritic-Cell-Priming Adjuvant in Vaccination.Tsukasa Seya, Masashi Shingai, Tomomi Kawakita
|May 28, 2022
Inactivated Whole Virus Particle Influenza Vaccine Induces Anti-Neuraminidase Antibodies That May Contribute to Cross-Protection against Heterologous Virus Infection.Chimuka Handabile, Toshiki Sekiya, Naoki Nomura
|Nov 27, 2021
Abnormal Blood Coagulation and Kidney Damage in Aged Hamsters Infected with Severe Acute Respiratory Syndrome Coronavirus 2.Marumi Ohno, Michihito Sasaki, Yasuko Orba
Pageof 1
Frequent Collaborators
3 joint publications
Marumi Ohno
3 joint publications
Tomomi Kawakita
2 joint publications
Yasuhiko Suzuki
2 joint publications
Tsukasa Seya
2 joint publications
Hiroshi Kida
1 joint publications
Michihito Sasaki
1 joint publications
Yasuko Orba
1 joint publications
Osamu Ichii
1 joint publications
Hirofumi Sawa
1 joint publications
Misako Matsumoto
